The regulated expression of Epstein-Barr virus. III. Proteins specified by EBV during the lytic cycle by Bayliss, G J & Wolf, Hans J.
J. gen. Virol. (1981), 56, 105-118. Printed in Great Britain 
Key words: EB V/protein synthesis/regulation~antigens 
105 
The Regulated Expression of Epstein-Barr Virus. III. Proteins Specified 
by EBV During the Lyric Cycle 
By GARY JAMES BAYLISS* AND HANS WOLF 
Max yon Pettenkofer Institute, Pettenkoferstrasse 9a,8000 Munich 2, West Germany 
(Accepted 15 April 1981) 
SUMMARY 
The experiments how that 30 virus-induced or virus-specified proteins were 
synthesized in Raft ceils after superinfection with Epstein-Barr virus (EBV) derived 
from P3HR1 cells. Using a combination of pulse labelling, application of 
cycloheximide blocks at different times post-infection, treatment with amino acid 
analogues and inhibition of DNA synthesis it was shown that three groups of 
proteins appear in Raji cells after superinfection; the synthesis of the proteins in any 
one group appears to be coordinately regulated. Amongst the six virus-induced 
proteins which were synthesized immediately after release from an early cyclo- 
heximide block one would expect o find those proteins essential for the transition 
from EBNA to EA synthesis. Using human sera with differing specificities for the 
various antigen groups 11 proteins were identified as being specifically precipitated 
by sera having high titres against the EBV-induced early antigen complex. 
INTRODUCTION 
Epstein-Barr virus (EBV) has a very restricted host range, being limited to B-lymphocytes 
of primates. Infection of these cells with EBV leads to immortalization ofthe cell rather than 
to a lytic infection (Diehl et aL, 1969; Gerber et al., 1969) and the transformed cells carry the 
virus genome, express virus-determined antigens and in some cases pontaneously enter into a 
cycle of virus production (Miller et aL, 1972). Cells of the Raji line carry between 50 and 60 
viral genomes, most of which are present as episomal-like structures rather than being 
integrated into the host genome (Tanaka & Nonoyama, 1974). The expression of the virus 
genome within these cells is limited to a single viral antigen: the EBV-determined nuclear 
antigen (EBNA). Treatment of these cells with iododeoxyuridine (IdUrd) (Glaser & 
Nonoyama, 1974), phorbol esters (zur Hausen et aL, 1978), butyric acid (Luka et al., 1979), 
antibodies directed against human IgM (Tovey et aL, 1978) and antibodies directed against 
lymphocyte cell surface proteins (Bayliss & Wolf, 1979) leads to the synthesis of a second 
group of viral antigens - the early antigen (EA) complex which includes nuclear, cytoplasmic 
and membrane components. It has not been possible to induce a fuUy lytic cycle in Raji cells 
by the various treatments listed above. Superinfection of Raji ceils, however, leads to a lytic 
cycle with release of progeny virus (Yajima & Nonoyama, 1976); up to 50% of the infected 
cells express virus capsid antigen (VCA) or EA (Bayliss & Nonoyama, 1978; Seigneurin et 
al., 1977). It has been reported that at least nine virus-induced proteins could be identified in 
superinfected Raji (Raji SI) cells (Bayliss & Nonoyama, 1978) and that these proteins could 
be divided into two groups with respect o the dependence of their synthesis upon the 
replication of viral DNA. Further studies (Wolf & B ayliss, 1978) allowed the identification of 
three groups of coordinately synthesized proteins in superinfected Raji cells. In many ways 
these groups resembled the three coordinately synthesized groups of proteins defined by 
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Honess & Roizman (1974, 1975) in herpes implex virus-infected cells. Our previous tudies 
on proteins specific for EBV-infected cells (Bayliss & Nonoyama, 1978; Wolf & Bayliss, 
1978) were restricted to observations made on nine virus-induced proteins and no correlation 
could be made between the biochemically defined groups of proteins and the immunologi- 
cally defined antigen complexes. Since then immunoprecipitation studies on proteins extracted 
from EBV-producing cell lines, chemically induced cells and virus particles (Kallin et al., 
1979; Mueller-Lantzsch et aL, 1979; Thorley-Lawson, 1979) have shown that the EA 
complex contains at least 5 and perhaps as many as 16 proteins and that the VCA complex 
contains 2 major proteins (150 and 140 × 103 daltons) (Thorley-Lawson, 1979). The mol. wt. 
of these antigenically defined proteins resemble the mol. wt. described for a number of the 
previously identified proteins in Raji SI cells (Bayliss & Nonoyama, 1978; Wolf & Bayliss, 
1978). In this study we report the identification of 30 proteins pecific for Raji SI cells with 
mol. wt. between 150 x 103 and 29 x 103, we classify them according to their regulatory 
properties and show that 11 proteins are specifically precipitated by antisera having high titres 
against the EBV EA complex. 
METHODS 
Tissue culture. P3HR1 cells were cultured in 32 oz prescription bottles at 37 °C in RPMI 
1640 medium supplemented with 10% heat-inactivated foetal bovine serum. When the cells 
reached a density of 106 cells/ml they were diluted 1:3 with fresh medium. Under these 
conditions the viability of the cultures remained high (over 95 % by trypan blue exclusion). 
The cultures contained approx. 10% VCA-positive cells after maturation at 31 °C for several 
days. In order to increase the number of VCA-positive cells some cultures were treated with 
phorbol-12-mystrate-13-acetate (40 ng/ml, procedure as described by zur Hausen et aL, 
1978). Raji cells were cultu:'ed under similar conditions and were used as target cells for 
superinfection with EBV as described below. 
EBV stock preparation. Cultures of aged P3HR1 cells were centrifuged at 4000 g for 
15 rain at 4 °C to pellet cells and cellular debris. The clarified supernatants were centrifuged 
at 27 000 g for 2 h at 4 °C to pellet he virus. The resulting pellets were resuspended in a small 
volume (5 ml/1 of original culture) of tissue culture medium and stored at -138 °C. 
Preliminary experiments indicated that whilst many virus stocks were able to induce EA 
synthesis in Raji cells they were unable to induce virus VCA synthesis. For this reason all 
virus stocks were pretested for their ability to induce the synthesis of late proteins as 
described previously (Bayliss & Nonoyama, 1978). Under ideal conditions each litre of 
culture supernatant yielded enough virus to superinfect between 2 × 107 and 4 x 107 Raji 
cells with production of VCA in up to 50% of the cells within 12 h after infection. 
Radiolabelling of cells. Ceils were collected by low-speed centrifugation and resuspended 
at a density of 2 × 106 cells/ml in methionine-free MEM culture medium supplemented with 
2% heat-inactivated foetal bovine serum, containing between 10 and 50 /aCi/ml [35S]- 
methionine. The cells were returned to 37 °C. After the pulse the cells were washed with cold 
phosphate-buffered saline and were then analysed on SDS-polyacrylamide g ls directly or 
following immunoprecipitation. 
Immunoprecipitation. The washed, labelled cells were resuspended in cold IP buffer (1% 
Triton X-100, 0.1% SDS, 0.137 M-NaC1, 1 mM-CaC12, 1 mM-MgC12, 10% glycerol, 20 
mM-tris-HC1 pH 9, 0.01% NaN 3 and 1 gg/ml phenylmethylsulphonyl fluoride) at a 
concentration of 106 cells/ml and disrupted by sonication (Branson, microtip at maximum 
output for 10 s), and incubated on ice for 30 min. The extracts were clarified by centrifugation 
at 180000 g for 30 min at 4 °C. In order to remove proteins which interact non-specifically 
with Staphylococcus aureus protein A absorbant the extracts were incubated with protein A 
coupled to Sepharose beads (Pharmacia) for 30 min at room temperature using 10 mg 
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beads/ml extract. The preabsorbed extract was mixed with 10 /tl EBV-positive or 
EBV-negative serum which adbeen preincubated for 30 rain with an extract prepared from 
10 ~ unlabelled EBV-negative lymphoblastoid cells (BJA-B cells) at room temperature. Three 
mg of preswollen protein A beads were th n added and after a further 30 min at room 
temperature the beads were washed with IP buffer until the washings contained no detectable 
radioactivity. The washed beads were resuspended in electrophoresis sample buffer and 
heated to 100 °C for 5 rain to dissociate the immune complexes. The supernatant was 
analysed on polyacrylamide slab gels as described below. These procedures were adapted 
from methods described by Kessler (1975) and Thorley-Lawson (1979). 
The following sera, obtained from the virus diagnostic laboratory of our institute, were 
used in the immunoprecipitation studies described in this paper: 6566-EBNA 1: 32, EA:0; 
VCA 1:2048; 7070-EBNA 1:32; EA 1:4096; VCA 1 : 16 384; 8463-EBNA 1:32; EA 0; 
VCA 1: 1024. All three sera had membrane antigen (MA) titres higher than 1:320. In some 
experiments a pool of serum was used; this had the following titres: EBNA 1:400, EA 1 : 1200, 
VCA 1:6600, MA greater than 320. Negative control sera were also used; these contained no 
detectable antibodies against any of the EBV-determined antigens. Thetitres quoted above 
were obtained by indirect fluorescent antibody staining techniques described elsewhere: 
EBNA (Reedman & Klein, 1973), EA (Henle et al, 1970), VCA (Henle & Henle, 1966) and 
for MA an adaption of the technique using ferritin-coupled anti-human IgG (Silvestre t al., 
1971) to the indirect fluorescent staining technique. 
SDS-polyacrylamide slab gel electrophoresis (PAGE). Samples were dissolved in 
electrophoresis sample buffer (50 mM-tris-HCl pH 7; 2% SDS; 5% 2-mercaptoethanol; 
30% sucrose) and heated to 100 °C for 5 rain; with some samples it was necessary toreduce 
the viscosity by sonication as described above. The resolving gel contained 10% acrylamide, 
0.26 % diallyltartardiamide (DATD), 0.1% SDS and 0.375 M-tris-HC1 pH 8.5, the gel ength 
was 15 era; the stacking el contained 3 % acrylamide, 0-08 % DATD, 0.1% SDS and 0.12 
M-tris-HC1 pH 7. Polymerization was initiated by adding ammonium persulphate and 
TEMED. The upper and lower buffer tanks contained 0.025 M-tris, 0.192 M-glycine and 
0.1% SDS (pH 8.5). Electrophoresis was carried out at room temperature using a constant 
current of 5.3 mA/cm 2 and continued until the leading front reached the end of the gel. The 
gels were fixed and stained for 1 h in a mixture of water, acetic acid and isopropanol (4: 1: 1) 
containing 0.1% Coomassie Brilliant Blue, destained in a mixture of water, acetic acid and 
isopropanol (8: 1:1) and dried on to Whatman 3M filter paper under vacuum. Kodirex X-ray 
film or LKB 2208 Ultrofilm 3H were used to prepare autoradiograms of the dried gels. The 
apparent mol. wt. of the proteins were estimated by comparison with a set of standard 
proteins (Escherichia coli RNA polymerase 160 x 103, 155 x 103 and 40 x 103 mol. wt. - a 
gift from Boehringer Mannheim - phosphorylase B 94 x 103 mol. wt., bovine s rum albumin 
68 × 10 a mol. wt. and carbonic anhydrase 30 × 103 mol. wt.); approx. 200 ng of each 
polypeptide were applied per slot. 
Metabolic inhibitors. Cycloheximide (CH) is an inhibitor of protein synthesis by preventing 
the translation of messenger RNA but not transcription. If added to virus-infected cells before 
the initiation of viral mRNA translation only those transcripts will be synthesized which can 
be made using the host transcription system; such proteins may be called alpha (Honess & 
Roizman, 1974), immediate early (Rakusanova etal., 1971) or primary proteins. Addition of 
CH to infected cells after the initiation of primary but before secondary protein synthesis will 
permit the accumulation fmRNA for secondary proteins but not their synthesis. Similarly, 
in systems having tertiary protein synthesis addition of CH to ceils after initiation of 
secondary protein synthesis will allow the accumulation fmRNA for the tertiary proteins. 
Removal of CH followed by a short pulse labelling will allow the identification of proteins 
translated from the pool of mRNA built up during the CH block. The drug was added to 
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cultures at a concentration of 50 gg/ml, and at the end of the treatment the inhibitor was 
washed from the cells with cold (4 °C) medium containing actinomycin D (2 gg/ml) to 
prevent further mRNA synthesis. The proteins ynthesized immediately after removal of the 
CH block were labelled in the presence of actinomycin D. Canavanine and azetidine, 
analogues of the amino acids arginine and proline respectively, were added to the cells at 500 
gg/ml. The cells were labelled in the presence of the analogues at the times indicated in the 
figure legends. Canavanine was used in arginine-free medium and azetidine in proline-free 
medium. DNA synthesis was inhibited with three different drugs: phosphonoacetic a id 
(PAA, 200 gg/ml), hydroxy-urea (HU, 4 mg/ml) or cytosine arabinoside (AraC, 50 gg/ml). 
The three inhibitors are reported to have different effects on the synthesis of host, endogenous 
viral and exogenous viral DNAs (Bayliss & Nonoyama, 1978; Mele et al., 1974; Yajima & 
Nonoyama, 1976). The action of the three inhibitors is further described in the discussion. 
Inhibitors were prepared as 100 times concentrates in Hanks' buffered saline, sterilized by 
passage through 0.22/am filters and stored at --20 °C until required. 
RESULTS 
Time-ordered appearance of proteins ynthesized in superinfected Raft cells 
Actively growing Raji cells were harvested by low-speed centrifugation a d mixed with an 
appropriate dilution of an EBV stock which had been pretested for its ability to induce late 
virus protein synthesis and inhibit host cell protein synthesis. Cells were shaken together with 
the virus for 1 h at room temperature, diluted to 2.5 x 105 cells/ml with MEM containing 2% 
foetal bovine serum, dispensed into culture tubes (106 cells/tube) and incubated at 37 °C in a 
CO2 incubator. At various times after infection cultures were pulse-labelled (30 min) and 
prepared for SDS-PAGE. Fig. 1 illustrates the results of such an experiment. Mock-infected 
cells were prepared similarly excepting that the infection was done with virus-free culture 
medium. During the first 6 h after infection there appeared to be a slight stimulation of host 
cell protein synthesis; after this time the host proteins disappeared from the profiles and by 
24 h post-infection very few host proteins can be identified. Previous experiments (Bayliss & 
Nonoyama, 1978) indicated that a single new protein could be identified in Raji SI cells 
shortly after the onset of infection; however, close inspection of the profiles presented in Fig. 1 
reveals that six proteins (120, 110, 105, 102, 63, 54) were synthesized early after infection. 
Most of these proteins were made in small amounts and migrated close to host proteins, 
which may explain our previous failure to identify these proteins. The synthesis of these 
proteins increased until about 6 h post-infection and then began to decline. At this time a 
second group of proteins began to appear (150, 138/135, 90, 83, 80, 49, 45, 40, 35 and 33), 
their synthesis increasing steadily until about 12 h post-infection and then declining slightly. 
One major exception to this observation is protein 138/135, the synthesis of which was 
considerably reduced after 12 h post-infection; this band is a complex of two virus-induced 
proteins and one host protein. Band 90 is also a doublet, which was resolved in some gels but 
not in others. The last protein to appear in Raji SI cells is 143; its synthesis was initiated 
between 10 and 12 h post-infection and continued until 24 h post-infection when the 
experiment was terminated. The rather abrupt appearance of virus proteins at 8 h 
post-infection is partially artefactual since at this time host protein synthesis had considerably 
declined and in addition the amount of incorporated label dropped. It was therefore necessary 
to use two-stage xposures of the gel shown in Fig. 1, so that whilst the virus proteins are 
present in proportionally greater amounts the absolute amount present at 6 and 8 h may not 
drastically differ. When the tracks M 1, 2, 4 and 6 are exposed for the same l ngth of time as 
the later tracks it becomes impossible to analyse the gel due to the ongoing host synthesis. 
M1 
¢- 
2 
EB V-induced protein synthesis 
Time of pulse (h post-infection) 
6 8 10 12 16 20 24 
~/5 
109 
Fig. 1. PAGE analysis of proteins synthesized in superinfected Raji SI cells at different times after 
infection. The infected cells were labelled at the times indicated above the tracks and prepared for 
PAGE as described in Methods. A mock-infected sample is labell d MI. Proteins induced by 
superinfection are indicated bya dot at the left ofthe track. The numbers referring to the virus-induced 
proteins are their mol. wt. × 10 -3. Approx. 65/~g protein were applied to each slot. Due to the decrease 
in incorporation f [ 3~S]methionine late after infection it was necessary to prepare two autoradiograms 
from the same g l and cut and reassemble them to allow identification of proteins at late times after 
infection. 
Effect of cycloheximide inhibition on the synthesis of virus-induced protein synthesis 
CH was added to Raji SI cells at various times after infection. At 12 h post-infection the 
drug was washed from the cultures and the cells were pulse-labelled (30 min) in the presence 
of actinomycin D. From the data presented in Fig. 2 it is apparent that when superinfected 
cells were treated with CH at 0 or 2 h post-infection that after removal of the drug six 
virus-induced proteins were observed (proteins 120, 110, 105, 102, 63 and 54). When CH was 
added at 6 or 8 h post-infection subsequent release of the block led to the synthesis of 
additional proteins 150, 138, 90, 80, 49, 45, 40, 35 and 33, although in lesser amounts than in 
untreated cultures and it was also noticeable that the synthesis of proteins 120, 110, 105, 102, 
63 and 54 had decreased. When the drug was added later than 10 h post-infection little effect 
was noticed except that proteins 143 and 83 were made in reduced amounts. These 
observations suggest hat the virus-induced proteins belong to three groups: primary proteins 
110 
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(b) Duration of CH treatment (h) 
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Fig. 2. (a) Effect of cycloheximide (CH) on the synthesis of proteins in Raji SI cells. CH was added to 
cultures of Raji SI cells at the times indicated and washed from the cultures at 12 h post-infection (in the 
presence of actinomyein D). The samples were labelled and prepared as described in Fig. 1. (b) Effect of 
cycloheximide (CH) treatment on the synthesis of proteins in uninfected Raji cells. CH was added to a 
culture of uninfected Raji ceils and samples were removed at various times. The duration of the CH 
block is given above the tracks in this figure. The cells were pulse-labelled and prepared for PAGE. The 
two CH-inducible proteins are indicated by dots placed to the left of the tracks. Approx. 65/~g protein 
were applied to each slot. Overexposure of the gel did not reveal additional bands. 
that can be synthesized in the absence of prior protein synthesis; secondary proteins that 
require the prior synthesis of proteins but once their synthesis is under way that of proteins 
begins to decline; tertiary proteins, the synthesis of which is initiated next, but does not 
appear to preclude further synthesis of secondary proteins. 
Treatment of uninfected Raji cells with CH lead to the synthesis of two proteins which are 
also induced by superinfection (120, 102) (Fig. 2b). This observation may indicate that CH 
partially induced the endogenous EBV genomes. 
Analysis of virus-induced proteins by immunoprecipitation 
Fig. 3 (a) illustrates the proteins precipitated from Raji SI cells by sera containing 
antibodies against he various EBV antigens. The titres against he various antigen groups are 
shown in the figure. Cells were labelled from 12 to 16 h post-infection and then prepared for 
immunoprecipitation as described in Methods. The three profiles presented in Fig. 3 (a) were 
selected from 16 immunoprecipitates prepared with different sera. Serum No. 7070 
precipitates all proteins so far found to be accessible for immunoprecipitation i  extracts of 
Raji SI cells. Other sera containing antibodies against VCA and EA (EA+VCA + sera) 
precipitated subsets of this population (data will be presented elsewhere). From this figure it is 
possible to conclude that part of the 138/135 and part of the 90/88 complexes are specifically 
precipitated by EA+VCA + sera as are proteins 80, 70, 63, 45, 40, 38, 37 and 31. It is not 
possible to define members of the VCA complex since all the sera used in this study were also 
positive for early and late membrane antigens (EMA and LMA). The precipitates prepared 
using a negative control serum (ND) contained so few counts that it was necessary to 
overexpose the gel by a factor of 5 in order to detect he non-specifically precipitated proteins. 
In Fig. 3 (b) an immunoprecipitation f proteins from Raji SI cells labelled early (2 to 6 h) or 
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Fig. 4. Effect of amino acid analogues on the synthesis of virus-induced proteins in Raji cells. 
(a) Canavanine (CAN) or azetidine (AZ) were added to Raji SI cells at 0 h post-infection, the cells 
were labelled at 12 h post-infection and prepared for PAGE analysis as described. Proteins normally 
seen in Raji SI cells (track SI) are indicated with a dot and proteins appearing only after treatment 
with canavanine are indicated by an open circle. Approx. 65 gg protein were applied to the gel. 
(b) Immunoprecipitation f proteins from Raji cells treated with azetidine. Raji ceils were labelled 
from 2 to 6 or 12 to 16 h post-infection, azetidine-treated cells from 12to 16 h post-infection and 
immunoprecipitates prepared using negative (ND) or positive (P) sera. The samples (in order of 
appearance in the figure) contained 5 × 102, 2 × 102, 104, 103 and 102 ct/min/50 gl. Specifically 
precipitated proteins are indicated by a square to the left of the profiles. 
late (12 to 16 h) after infection (using serum 7070) is presented. Immunoprecipitates from the 
samples labelled at early times after infection contained many more non-specifically 
precipitated proteins than the samples labelled late in the infectious cycle. This is probably 
due to the inefficient inhibition of host protein synthesis at early times after infection. Several 
of the proteins synthesized at early times during the infectious cycle and precipitated by 
serum 7070 were identified in Fig. 3 (a) as being specifically precipitated by EA+VCA + sera 
(138, 70, 63 and 47). Comparison of  these results with the results presented in Fig. 2(a)  
suggests that most of these polypeptides are secondary proteins. We therefore prepared 
immunoprecipitates from cells labelled immediately after release from a CH block applied at 
4 or 8 h post-infection. Fig. 3 (c) illustrates the results from such an experiment, in which we 
used a pool of EA+VCA + antisera. 
These profiles confirm the supposition that proteins specifically precipitated with 
anti-EA-positive sera belong to the group of secondary proteins (138, 90, 80, 47, 40) with the 
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Fig. 5. Effect of inhibitors of DNA synthesis on the synthesis of virus-induced proteins in Raji SI 
cells. (a) MI, Uninfected Raji cells; SI, superinfeeted Raji cells, - ,  no inhibitor; ARA, cytosine 
arabinoside, HU, hydroxy-urea; PAA, phosphonoacetic acid.The inhibitors were added to the 
cells at the time of infection and the ceils labelled at 12 h post-infection (i  the presence of inhibitor) 
and prepared for PAGE as described. Virus-specified proteins ar  i dicated by a dot to the left of the 
untreated SI track. (b) Immunoprecipitates prepared from SI cells treated with the inhibitors of DNA 
synthesis using negative serum (ND) or positive sera (P). The immunoprecipitation contained (in order 
of appearance in the figure) 1.5 × 102, 1.5 × 103, 2 × 102, 8 × 103, 8 × 102, 14 × 103 ct/min/50 gl. 
exception of protein 63 which is a primary protein. Note also that CH-inducible protein 102 is 
also precipitated from CH-treated, uninfected Raji cells by this pool of serum. 
Effect of amino acid analogues on the synthesis of virus-indueed protein synthesis 
In the preceding experiments we demonstrated an apparent relationship between three 
groups of virus-induced proteins with respect o their coordinated synthesis. In order to test 
the hypothesis that the control elements are in fact virus-induced proteins and not some other 
factor, it is necessary to observe the effect of synthesis of defective primary proteins on the 
synthesis of secondary and tertiary proteins. To this end Raji cells were superinfected in the 
presence of either canavanine or azetidine and incubated with the drug until 12 h 
post-infection, at which time the cells were labelled in the presence of the analogue. The 
population of proteins synthesized under these conditions was analysed on SDS-poly-  
acrylamide gels and the result of one such experiment is presented in Fig. 4 (a). The presence 
of canavanine prevented the synthesis of most proteins with the exception of three proteins 
(120, 102 and 49). In addition to these three proteins a number of previously unidentified 
proteins were observed (marked with open circles in Fig. 4 a). The origin of these remains 
obscure; they may represent proteins which were not correctly processed (cleavage, 
glycosylation, phosphorylation or sulphation) due to the presence of the amino acid analogue. 
Alternatively, they may be primary proteins which were not previously identified due to 
insufficient accumulation i  the absence of canavanine. 
Azetidine, although it inhibits the synthesis of many virus proteins does not have the 
drastic effect of canavanine, since nine proteins are synthesized in its presence (138, 120, 110, 
102, 90, 80, 49, 45 and 35). Since treatment of the cells with amino acid analogues reduces 
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Table 1. Summary of the EBV-induced proteins 
Time of 
Observed Specifically maximum Sensitivity Sensitivity to inhibition withll 
precipitated synthesis to CH 
DIRT I P ~  by EA+ sera (h poit-infection) blockg 
, 
PAA HU AraC CAN AZ 
+S *S S S S  
+S +S S S S 
NS NS NS S NS 
NS NS 
NS NS NS S NS 
* Polypeptide; the numbers used to identify the various polypeptides are the apparent mol. wt. x lo-'. 
Observed in total cell extracts analysed directly in SDS polyacrylamide gels. 
$ Only seen after enrichment by immunoprecipitation. 
8 1, Primary protein; 2, secondary protein; 3, tertiary protein. 
I I  PAA, phosphonoacetic acid; HU, hydroxy-urea; AraC, cytosine arabinoside; CAN, canavanine; AZ, 
azetidine; S, sensitive to inhibitor; NS, not sensitive; f S, synthesis of the polypeptide is considerably reduced 
in the presence of the inhibitor. 
¶These bands contain more than one polypeptide, 1381135 is a triplet containing two virus-induced proteins 
and one host protein. The bands 90188 and 35134.5 are doublets containing two virus-induced proteins. 
** EA specificity resides in one member of the multiple band. 
the synthesis of total protein considerably, immunoprecipitates were prepared from treated 
cultures in order to detect proteins synthesized in small amounts. The results from such an 
experiment using azetidine-treated cells failed to reveal any additional proteins (Fig. 4 b). The 
Raji SI cells treated with canavanine remained negative in the indirect fluorescent antibody 
staining test (FA test) for EBV, EA or VCA whereas those treated with azetidine were 
positive for EA. 
Dependence of virus-inducedprotein synthesis on DNA replication 
Raji SI cells were treated with either cytosine arabiioside (AraC), hydroxyurea (HU) or 
phosphonoacetic acid (PAA) as described in Methods from 0 to 12 h post-infection. The cells 
were then pulse-labelled in the presence of the inhibitors. The results of such an experiment 
are presented in Fig. 5 (a). From these profiles it is apparent that inhibition of DNA synthesis 
with PAA or HU prevents the synthesis of the tertiary proteins and, in addition, reduces the 
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quantity of protein 150, traces of which can be detected in Fig. 5 (a). Analysis of the samples 
by immunoprecipitation (Fig. 5b) revealed that proteins 150 and 143 are synthesized, 
although in reduced amounts. Inhibition of DNA synthesis with AraC has similar effects; 
however, its inhibitory activity appears to be more complete since proteins 150 and 143 could 
not be detected even after immunoprecipitation. All Raji SI cells treated with the inhibitors 
were positive for EA but negative for VCA in the FA test. Table 1 summarizes all the data 
presented in these xperiments. 
DISCUSSION 
The sequential synthesis of virus-induced proteins observed in the experiment presented in
Fig. 1 suggested to us that the synthesis of proteins induced byEBV within Raji SI ceils may 
be coordinately regulated by mechanisms similar to those described by Honess & Roizman 
(1974, 1975), Rakusanova et al (1971) and Wolf & Roizman (1977) in HSV-infected cells. 
To test this hypothesis we carried out experiments using cycloheximide, canavanine and 
azetidine (Fig. 2 and 4) and inhibitors of DNA replication. One major difference between the 
Raji SI cell and the HSV-infected cell is that all Raji cells already contain EBV genomes 
which are partially expressed. It is therefore not justified to assume that the EBV and HSV 
systems are exactly analogous. For this reason we have refrained from using the alpha, beta, 
gamma nomenclature introduced by Honess & Roizman for HSV and have defined the three 
groups of proteins as primary, secondary and tertiary groups. The experiments shown in Fig. 
2 (a, b) indicate that the synthesis of secondary proteins is dependent upon the prior synthesis 
of primary proteins, and once the synthesis of secondary protein is under way, the synthesis 
of primary proteins is inhibited. Similarly, the synthesis of tertiary proteins is dependent upon 
the prior synthesis of secondary proteins. The synthesis of secondary proteins does not seem 
to be inhibited by tertiary proteins. Whether EBNA is required for the initiation of primary 
protein synthesis i not clear from these experiments. EBNA may be a primary protein itself 
or its synthesis may precede that of primary proteins and its presence may be a requirement 
for the initiation of further protein synthesis. The fact that the superinfection system is more 
complex than the lytic cycle following infection with HSV is reinforced by the possible 
activation of the endogenous EBV genomes after CH treatment. Although immuno- 
fluorescent staining could not detect EA in the CH-treated, uninfected Raji cells, the two 
CH-inducible proteins (120 and 102) identified in Fig. 2 (a, b) may be the first steps towards 
the expression of the immunologically defined EA complex without being part of it. 
Synchronization of the cells before CH treatment allows the synthesis of EA in uninfected 
Raji cells. These observations are identical to those reported by Hampar et al. (1976) who 
showed that addition of CH to Raji cells at the beginning of the S phase permitted the 
synthesis of EA 5 h after the removal of the inhibitor. The observation that the primary 
proteins appear in subgroups leads to the hypothesis that a sequence of events, specified by 
EBV, occurs immediately after infection and is essential for subsequent synthesis of EA. 
Further evidence that the primary phase of protein synthesis can be subdivided comes from 
the experiments using canavanine which, when added at the time of infection, prevented the 
synthesis of several but not all of the primary proteins (see Fig. 4 and 6). Full expression of 
the primary and partial expression of the secondary groups of proteins is observed when 
canavanine is replaced by azetidine (Fig. 4 and 6). This observation may indicate that more 
than one control mechanism ay operate the switch from primary to secondary synthesis, 
that one controlling element cannot be made in an active form in the presence of canavanine 
and that this element is required for full expression of primary proteins. This or these primary 
protein(s) can be synthesized in the presence of azetidine and permit a partial expression of 
the secondary group. Whether the full expression of the secondary group requires a second 
primary protein (which cannot be made in active form in the presence of azetidine) or whether 
transition from secondary a to secondary b group is controlled by a secondary a protein 
remains obscure. Addition of inhibitors of DNA synthesis before the onset of viral DNA 
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replication prevented the normal synthesis of tertiary proteins (Fig. 5). The effect of AraC 
was more drastic than the effect of PAA or HU. With AraC proteins 150 (which according to 
other criteria is a secondary protein) and 143 were not synthesized; PAA and HU permitted a 
very reduced synthesis of these two proteins. This difference in effect may be explained by the 
mode of action of the three inhibitors" PAA inhibits the replication of the infecting viral 
genomes but not of host or latent EBV genomes, HU on the other hand appears to prevent 
host and latent EBV DNA replication whilst permitting replication of the EBV genomes 
during productive infection, and AraC prevents all DNA replication (Bayliss & Nonoyama, 
1978; Mele et al, 1974; Yajima et al., 1976). Thus, if the mRNA for proteins 150 and 143 is 
transcribed from virus DNA with low efficiency, or the mRNA has either a short half-life, 
inefficient processing potential or low ribosome-binding capacity, then reduction in the 
amount of viral DNA available for transcription will have a greater effect upon the synthesis 
of these two proteins when compared to others; this would correspond with observations in
the HSV system (Wolf & Roizman, 1977). As the pool of virus DNA increases the amount of 
mRNA for proteins 150 and 143 available for translation will also increase, and since either 
Hid and PAA have only a partial effect on total viral DNA synthesis within the superinfected 
Raji cell it might be expected that small amounts of these proteins would be observed in the 
cells treated with these two inhibitors. The observation that inhibition of DNA synthesis 
prevents the normal transition from secondary to tertiary protein synthesis may indicate that 
the protein responsible for the switch acts indirectly by stimulating virus DNA synthesis (or 
in fact be the virus-coded DNA polymerase) rather than acting directly upon the viral genome 
as a regulatory protein to initiate transcription of a 'late' region. The results from the CH 
experiments or experiments done with amino acid analogues cannot differentiate between 
these two possibilities since addition of CH before the synthesis of a significant amount of 
viral DNA or synthesis of a defective DNA polymerase due to the presence of amino acid 
analogues may directly affect DNA synthesis as well. 
Immunoprecipitation experiments with Raji SI cells (Fig. 3, 4 b, 5 b) indicate that proteins 
specifically precipitated by EA+VCA + sera (138, 90, 80, 63, 45, 40, 38, 37 and 31) are 
members of the secondary protein group, with one exception, pp63, which is a primary 
protein. These results differ from those published by Mueller-Lantzsch et al. (1979) who have 
described five polypeptides specifically precipitated by anti-EA sera (having apparent mol. 
wt. of 120 x 103, 85 × 103, 35 x 103 and 16 x 103). These probably correspond to our 
proteins 138, 90 and 35, since the two proteins with lower mol. wt. would not have been 
resolved in our gel system. The reason for the additional proteins we have observed may 
have been the use of sera with differing specificities for the various components of the EA 
complex. The sera used by Mueller-Lantzsch et al. (1979) may have contained antibodies 
against a subset of the EA complex. This contention is supported by our unpublished 
observation that not all EA+VCA + sera precipitate the full spectrum of EA proteins, and by 
the observations of Henle et al. (1971) who demonstrated that sera derived from patients 
with different EBV-induced iseases have different specificities against subcomponents of the 
EA complex in the fluorescent antibody staining test. From the data presented it is apparent 
that the regulation of EBV-induced protein synthesis is complex and a classification i to 
primary, secondary and tertiary phases by experiments using CH inhibition is certainly not 
detailed enough. The first two groups can be subdivided on the basis of the results of 
experiments using amino acid analogues and inhibitors of DNA replication. Fig. 6 gives a 
summary of the data and shows the regulatory steps so far identified. Consideration of the 
immunoprecipitation analysis and the reported ivision of the EA complex into two com- 
ponents by fluorescent antibody staining (Henle et al., 197 I) suggests that phase 2 may be 
further subdivided. Indeed Mueller-Lantzsch et al. (1979) have shown that in phorbol 
ester-treated Raji cells only a partial expression of the EA complex occurs (proteins 85 and 
35) whereas cells which spontaneously produce virus (P3HR1 and B95) contained the 
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cells I* EBNA 
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Superinfected 120~ 110 54 138 e 45 e 150 s 31 e 143 
Raji cells ~PP 102 [ 105 48 90 e 35 ~ 40 e 29 83 
49 [ 63 e 80 e 33 
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Canavanine Immediate Azetidine DNA synthesis block 
added at 0 h CH Block added at 0 h Intermediate CH 
post-infection postdnfection block 
Fig. 6. A model for the sequence of events in Raji SI cells. The three major phases of protein synthesis 
(primary, secondary and tertiary) are defined by the response of the superinfected cells to cycloheximide 
blocks applied at different imes after infection. The primary and secondary phases are further 
subdivided according to the effect of amino acid analogues. Proteins marked with a superscript e are 
specifically precipitated by EA + sera. Protein 150 (s) is partially sensitive o inhibition by inhibitors 
of DNA synthesis, although it is synthesized immediately after release from an intermediate CH block. 
The status of EBNA within this scheme remains to be clarified. 
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remaining components of the EA complex which they were able to identify. Whether this 
partial expression of EA is due to a defective ndogenous genome which does not contain 
the information for the complete EA complex, or whether those EA proteins ynthesized in
induced Raji cells are defective and unable to induce the synthesis of the remaining EA 
proteins is not clear. These possibilities are presently under investigation. 
The authors are indebted to the excellent technical assistance of Mrs Gabriele Deby, and Professor 
Deinhardt for his support and interest. The work was supported byDFG Wo 227/2 and SFB 51. 
Note added in proof: during the process of submission of this paper R. J. Feighney, M. P. Farrell and 
J. S. Pagano published a paper extending our previous finding on kinetics and effects of inhibition of 
DNA synthesis to 29 proteins. They, in addition, give data on phosphorylation and cellular 
compartmentalization of the virus-induced cells (Journal of Virology, 1981, 37, 204-207). 
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